IBO.US Impact BioMedical, Inc.

Healthcare Biotechnology USA Stocks
5.14 USD
Close of Nov 14, 2026
2.43 10.47
Market cap
USD 44.4M
P/E
0.4x
P/B
4.39x
ROE
-47.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is IBO.US undervalued?

Graham number

The Graham number of Impact BioMedical, Inc. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Impact BioMedical, Inc. fundamental analysis

No fundamental analysis for Impact BioMedical, Inc. yet.

Impact BioMedical, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Impact BioMedical, Inc.

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that …

Full company profile